Active, not recruitingPhase 1NCT04483778

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Studying Atypical teratoid rhabdoid tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Seattle Children's Hospital
Principal Investigator
Catherine Albert, MD
Seattle Children's Hospital
Intervention
second generation 4-1BBζ B7H3-EGFRt-DHFR(biological)
Enrollment
68 enrolled
Eligibility
0-26 years · All sexes
Timeline
2020 – 2040

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04483778 on ClinicalTrials.gov

Other trials for Atypical teratoid rhabdoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Atypical teratoid rhabdoid tumor →

← Back to all trials